Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.
D000818:Animals; D002460:Cell Line; D002851:Chromatography, High Pressure Liquid; D003588:Cytopathogenic Effect, Viral / Q000187:drug effects; D017977:Deltaretrovirus / Q000187:drug effects* / Q000472:pathogenicity; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000494:pharmacology; D003842:Deoxycytidine Kinase / Q000378:metabolism; D005260:Female; D006041:Goats; D006801:Humans; D007941:Leukemia P388 / Q000378:metabolism; D051379:Mice; D013329:Structure-Activity Relationship; D013868:Thioinosine / Q000031:analogs & derivatives / Q000494:pharmacology; D016047:Zalcitabine
D003841:Deoxycytidine; D013868:Thioinosine; D016047:Zalcitabine; D003842:Deoxycytidine Kinase; C001789:4-nitrobenzylthioinosine